Application of delphinium ajacis monomer FYC-3 in preparation of medicine for preventing and treating severe heatstroke and cardiac dysfunction

Through the monomer of delphinia FYC-3, the inflammatory factor release of cardiac fibroblasts is inhibited and the apoptosis pathway is regulated, and the cardiac dysfunction caused by severe heat stroke is solved, which significantly reduces the damage to cardiomyocytes by heat strikes, and provides new drug selection.

CN119074724APending Publication Date: 2024-12-06THE FIRST AFFILIATED HOSPITAL OF GUIZHOU UNIV OF TRADITIONAL CHINESE MEDICINE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411246446.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-06
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The prior art is difficult to effectively prevent and treat cardiac dysfunction caused by severe heatstroke, especially the role of cardiac fibroblasts in heatstroke, which is still unclear, leading to cardiac dysfunction and multi-organ dysfunction.

Method used

The monomer of delphinium FYC-3 is used as a drug component to regulate the apoptosis pathways of Bax, Bcl-2, and Cleaved-caspase3 by inhibiting the release of inflammatory factors in cardiac fibroblasts, and reduce the damage to cardiomyocytes by heat strikes.

Benefits of technology

The monomer of delphinium FYC-3 significantly alleviates cardiac dysfunction after heat strikes, and provides new drug options to prevent and treat cardiac dysfunction caused by severe heatstroke by reducing the release of inflammatory factors and preventing apoptosis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119074724A_ABST
    Figure CN119074724A_ABST
Patent Text Reader

Abstract

The invention discloses application of delphinium ajacis monomer FYC-3 in preparation of a medicine for preventing and treating severe heatstroke heart dysfunction, the applicant finds that the delphinium ajacis monomer FYC-3 can relieve inflammatory factors secreted by heat strike heart fibroblasts and relieve the heart dysfunction through a large number of researches, and the delphinium ajacis monomer FYC-3 can be used for preparing the medicine for preventing and treating the severe heatstroke heart dysfunction. Wide application prospects are realized.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a novel drug application of delphinium monomer FYC-3, in particular to application of delphinium monomer FYC-3 in preparing a drug for preventing and treating severe heatstroke and heart dysfunction, belonging to the technical field of drugs. Background Art

[0002] Severe heat stroke (HS) is an acute heat-induced disease characterized by dysfunction of the temperature regulation center, failure of sweat gland function, and excessive loss of water and electrolytes. In severe cases, it may present with clinical manifestations such as central nervous system disorders, systemic inflammatory response syndrome, and multiple organ failure. Severe heat stroke is a high-mortality disease, and the risk of death is significantly increased in patients with concomitant cardiac dysfunction. Cardiac fibroblasts are immune cells in the heart. When stressed, they release proinflammatory factors that lead to cardiac dysfunction, but their role in heat stroke is still unclear.

[0003] The pathophysiology of severe heat stroke is that heat exposure causes cell damage and induces systemic inflammatory response syndrome, which is similar to the activation of endotoxins in sepsis, so it is also called "sepsis-like", which can eventually induce multiple organ dysfunction, among which the cardiovascular system is one of the most vulnerable target organs, and the incidence of combined cardiac dysfunction is 43.4-65.2%. An analysis of weather conditions and deaths in 272 cities in China from 2013 to 2015 showed that both cold and hot temperatures were associated with an increased risk of cardiovascular and pulmonary vascular diseases. In general, heat stroke caused a significant increase in patient deaths, and combined cardiovascular causes were the main factor. The regulation of the cardiovascular system plays a key role in the pathogenesis of heat stroke. Abnormalities in temperature regulation, blood pressure and perfusion function can lead to the occurrence of multiple organ dysfunction syndrome and even death. At present, there are few reports on the clinical characteristics and prognosis of heat stroke complicated with myocardial injury. Summary of the invention

[0004] The technical problem to be solved by the present invention is to provide an application of delphinium monomer FYC-3 in the preparation of drugs for preventing and treating severe heatstroke and heart dysfunction, thereby providing a new drug option for the prevention and treatment of severe heatstroke and heart dysfunction.

[0005] In order to solve the above technical problems, the technical solution of the present invention is as follows:

[0006] Application of delphinium monomer FYC-3 in the preparation of drugs for preventing and treating severe heatstroke and heart dysfunction.

[0007] As a preferred embodiment, the drug comprises delphinium monomer FYC-3 and pharmaceutically acceptable excipients.

[0008] As a preferred embodiment, the dosage form of the drug can be prepared into pharmaceutical preparations such as injection, oral solution, pill, powder, paste, tablet, granule, powder or capsule according to clinical needs.

[0009] Beneficial effects: Compared with the prior art, the applicant has found through extensive research that the delphinium monomer FYC-3 can reduce the secretion of inflammatory factors by cardiac fibroblasts induced by heat shock, alleviate cardiac dysfunction, and can be used to prepare drugs for the prevention and treatment of severe heatstroke and cardiac dysfunction, and has broad application prospects.

[0010] Delphinium (Consolida ajacis (L.) Schur) belongs to the genus Delphinium of the Ranunculaceae family. It is also known as colorful bird and large-flowered delphinium. It is an upright annual herb native to southern Europe and is now planted in all provinces of China. The whole plant, flowers, leaves, stems, roots and seeds of Delphinium plants contain different types of chemical components, mainly flavonoids and diterpenoid alkaloids, followed by polyphenols, organic acids, carboxylic acids, tannic acid, fatty acids, sterols, polysaccharides, saponins and proteins. As a traditional Chinese medicinal material, the roots and seeds of Delphinium plants are used as medicine. They are warm in nature, bitter in taste, and enter the lung, heart and stomach meridians. The "Chinese Medicinal Plant Atlas" points out: "Seeds: taken orally, can treat asthma and edema. Roots: mainly treat abdominal pain." It has the effects of relieving asthma and diuresis. Modern research has shown that this drug has medicinal effects such as analgesia, antioxidant, anti-inflammatory, anti-arrhythmic, anti-tumor, antispasmodic, analgesic, and insecticidal. Delphinidin can reduce retinal cell apoptosis in rats with retinal ischemia-reperfusion injury and has a neuroprotective effect, which may be related to the inhibition of apoptosis pathway protein expression. The diterpene alkaloids isolated from delphinidin were tested for antibacterial activity, and the results showed that they had significant antibacterial effects on Escherichia coli, Acinetobacter baumannii, Staphylococcus aureus, etc. Delphinidin glucoside can also induce endothelial cell autophagy through the AMPK-SIRT1 pathway, thereby inhibiting endothelial cell oxidative stress damage. Delphinidin can also protect endothelial cells by inhibiting the phosphorylation level of p38MAPK, thereby affecting the expression of genes related to oxidative stress. At present, there are no reports on the correlation between delphinidin and cardiac fibroblasts at home and abroad.

[0011] Based on the characteristic diterpene alkaloids of delphinium, the applicant newly extracted the chemical component FYC-3, and gave delphinium monomer FYC-3 to pre-treat cardiac fibroblasts before heat shock modeling. CCK-8 detection found that it can increase cell survival rate. At the same time, in order to clarify the effect of FYC-3 on inflammatory factors of fibroblasts, the ELISA results of cell supernatant after modeling showed that delphinium monomer FYC-3 can reduce the secretion of inflammatory factors by heat shock fibroblasts. To further verify the effect of FYC-3 on cardiomyocyte apoptosis after heat shock co-culture system, the applicant found that FYC-3 may prevent the increase of Bax and caspase-3 protein expression and the decrease of Bcl-2 protein expression by reducing the release of inflammatory factors caused by heat shock, thereby controlling the process of cell apoptosis.

[0012] The present invention establishes a heat shock model in vivo and in vitro, uses FYC-3 to intervene in cardiac fibroblasts, detects the level of inflammatory factors and myocardial cell apoptosis after heat shock, and clarifies the protective effect and possible mechanism of delphinium monomer FYC-3 in reducing severe heatstroke cardiac dysfunction by inhibiting the inflammatory response of cardiac fibroblasts. The results show that heat-shocked mice have cardiac dysfunction, increased inflammatory factors, and myocardial cell apoptosis. Heat shock causes cardiac fibroblasts to release inflammatory factors, and excessive inflammatory factors induce cardiac inflammation and cardiac dysfunction, and myocardial cell apoptosis. After administering delphinium monomer FYC-3, the release of inflammatory factors is reduced, and cardiac dysfunction is alleviated. The mechanism may be achieved by regulating the apoptosis pathways of Bax, Bcl-2, and Cleaved-caspase3. It can be seen from this that heat shock causes cardiac fibroblasts to release inflammatory factors, and excessive inflammatory factors induce cardiac inflammation and cardiac dysfunction, and myocardial cell apoptosis. After administration of delphinium monomer FYC-3, the release of inflammatory factors was reduced and cardiac dysfunction was alleviated. The mechanism may be achieved by regulating the apoptosis pathway, which has important guiding significance for further research on the pathogenesis and treatment of cardiac dysfunction in severe heatstroke. BRIEF DESCRIPTION OF THE DRAWINGS

[0013] Figure 1 These are ultrasound images of the hearts of mice in each group of the present invention;

[0014] Figure 2 is the left ventricular end-diastolic diameter diagram of each group of mice of the present invention;

[0015] Figure 3 is a graph of the left ventricular end-systolic diameter of each group of mice of the present invention;

[0016] Figure 4 It is the ejection fraction graph of each group of mice of the present invention;

[0017] Figure 5 is a graph of shortening scores of each group of mice of the present invention, *P<0.05vs.Normal group;

[0018] Figure 6 This is the immunohistochemical diagram of myocardial tissue of the present invention, note: ×200, A: Bax protein expression, B: Cleaved-caspase3 protein expression, C: Caspase3 protein expression, D: Bcl-2 protein expression;

[0019] Figure 7 The myocardial tissue immunohistochemical statistical analysis of the present invention, n = 6 / group, * P<0.05vs.Normal group, # P>0.05vs Normal group;

[0020] Figure 8 It is the graph of IL-6 level in heat-shocked mice of the present invention, n=6 / group, *P<0.05vs.Normal group;

[0021] Fig. 9 These are the immunofluorescence images of mouse cells of the present invention, A: immunofluorescence detection of cardiac fibroblasts B: immunofluorescence detection of myocardial cells;

[0022] Fig.10 This is a graph showing the effect of heat shock at 43°C for different time periods on the viability of fibroblasts. n=5 / group, * P<0.05vs.control group;

[0023] Fig.11 This is a graph showing the effect of heat shock at different temperatures on the activity of fibroblasts in the present invention; n=5 / group, * P<0.05vs.control group;

[0024] Fig.12 This is the effect diagram of heat shock on the secretion of inflammatory factors in fibroblasts of the present invention. n=3 / group,*P<0.05vs.Normal group;

[0025] Fig.13 The figure is the effect of heat shock on the protein level in myocardial cells after co-culture of fibroblasts and myocardial cells in the present invention. A. Protein expression B: Statistical analysis, GADPH as an internal reference, n=3 / group,*P<0.05vs.Normal group, #P>0.05vs Normal group;

[0026] Fig.14 This is a flow chart of the extraction of delphinium monomer FYC-3 of the present invention;

[0027] Fig.15 This is a molecular structure diagram of the delphinium monomer FYC-3 of the present invention;

[0028] Fig.16 The effect of the delphinium monomer FYC-3 of the present invention on the activity of fibroblasts, n=6 / group, * P<0.05vs.control group;

[0029] Fig.17 This is a diagram showing the effect of the delphinium monomer FYC-3 of the present invention on the secretion of inflammatory factors in heat-shocked fibroblasts. n=3 / group, △ P<0.05vs.Normal group,*P<0.05vs.HS group;

[0030] Fig.18 The effect of pre-treatment of cardiomyocytes with Delphinium japonicum FYC-3 on cardiomyocyte apoptosis. A. Protein expression B: Statistical analysis. GADPH was used as an internal reference. n=3 / group, △ P<0.05vs.Normal group, # P>0.05vs.HS group;

[0031] Fig.19 The effect of the co-cultured fibroblasts and cardiomyocytes pretreated with Delphinium lycopersicum FYC-3 on cardiomyocyte apoptosis. A. Protein expression B: Statistical analysis. GADPH was used as an internal reference. n=3 / group, △ P<0.05vs.Normal group,*P<0.05vs.HS group, # P>0.05vs.HS group. DETAILED DESCRIPTION

[0032] In order to verify the mechanism of action of delphinium monomer FYC-3, the present invention established heat shock models in vivo and in vitro, used FYC-3 to intervene in cardiac fibroblasts, detected the levels of inflammatory factors and cardiomyocyte apoptosis after heat shock, and clarified the protective effect and possible mechanism of delphinium monomer FYC-3 in alleviating cardiac dysfunction in severe heatstroke by inhibiting the inflammatory response of cardiac fibroblasts.

[0033] 1. Materials and Methods

[0034] 1. Experimental Animals

[0035] 6-8 week old SPF male C57BL / 6 mice were selected. They were provided by Guizhou University of Traditional Chinese Medicine and purchased from Chongqing Tengxin Biotechnology Co., Ltd. (Animal Production License No.: SCXK (Beijing) 2019-0010).

[0036] Feeding conditions: The animals were raised according to animal feeding conditions, with the indoor temperature set at 23±1℃ and humidity at 50%-60%, and free access to water and food every day. The light and dark time were 12h each day. This experiment was approved by the Ethics Committee of Guizhou University of Traditional Chinese Medicine. Animal experiments complied with the requirements of international experimental animal ethics.

[0037] 2. Grouping and modeling

[0038] 20 C57BL / 6 mice were divided into 2 groups, normal group (Normal) and heat shock group (HS), 10 mice in each group, fed with standard feed, free access to food and water, and the experiment was carried out after 1 week of adaptation. Normal group: conventional feeding, free access to water, no treatment. HS group: heat shock modeling of mice: the modeling mice were placed in a simulated climate chamber, the temperature in the climate chamber was set to 37 degrees Celsius, the humidity was set to 70%, the anus temperature of the mice was measured every hour, when the body temperature rose to 41°C, the body temperature was measured every 10 minutes, when the body temperature was 42°C, the modeling was successful, and the mice were removed.

[0039] 3. Specimen collection

[0040] 12 hours after modeling, the mice's response to stimulation, activity and death were observed; cardiac ultrasound was performed to detect cardiac function; blood was collected from the eyeballs to detect changes in inflammatory factors; and the heart was taken for immunohistochemistry to detect the level of apoptotic proteins.

[0041] 4. Cardiac ultrasound

[0042] The mice in the normal group and the model group were subjected to cardiac color Doppler examination 12 hours after modeling. Before the examination, the C57 mice were anesthetized with isoflurane gas, and the mouse hair beside the left sternum was cut with scissors. The left ventricular end-diastolic diameter (LVIDd), left ventricular end-systolic diameter (LVIDs), shortening fraction (FS), and ejection fraction (EF) were measured by two-dimensional ultrasound and M-mode ultrasound beside the sternum using ultra-high resolution small animal color Doppler (Vevo2100). All parameters were measured in 3 consecutive cardiac cycles and the average value was taken after measurement.

[0043] 5. ELISA and immunohistochemistry

[0044] According to the ELISA reagent instructions: before the test, all reagents and samples are balanced to room temperature, whole blood is centrifuged at 12000r / min for 10 minutes, and serum is collected for use. Prepare all required reagents and working concentration specimens, soak the ELISA plate, add standard, add sample, add detection antibody, incubate, wash, add substrate to color, add stop solution, and read the test. Immunohistochemistry: wash the slide, embed tissue, slice, fish out tissue, dewax, antigen repair, serum blocking, add primary antibody, add secondary antibody, add SABC, counterstain, dehydrate, and seal.

[0045] 6. Main reagents for cell experiments

[0046] CCK-8 kit (Japan Tongren); Caspase-3Antibody, Cleaved Caspase-3, Bcl-2, Bax (CST); IL-6ELISA Kit, IL-1βELISA Kit, TNF-a ELISA Kit (Lianke).

[0047] 7. Cell culture

[0048] 7.1 Primary cardiac fibroblast culture

[0049] Neonatal rat cardiac fibroblasts were obtained from newborn C57BL / 6 mice. The mice were anesthetized by intraperitoneal injection of sodium pentobarbital (100 mg / kg), and the death of the mice was confirmed by heart palpation. Then, the hearts of the newborn mice were isolated and cut into pieces. Then, the heart tissue was rinsed with phosphate buffered saline (PBS) and digested with Liberase TH digestion enzyme at 37°C for 15 minutes. The cell culture supernatant was transferred to complete medium (DMEM containing 10% fetal bovine serum) to terminate the digestion. The remaining tissue was further digested by enzyme digestion at 37°C for 15 minutes. The digestion was repeated 3 to 4 times to separate all cells from the heart tissue. The cell suspension was collected and centrifuged at 250×g for 5 minutes. The supernatant was removed and the pellet was resuspended in complete medium. The cell suspension was transferred to a culture dish and cultured in an incubator at 37°C and 5% CO2 for 60 minutes. Fibroblasts and cardiomyocytes were separated by differential attachment method. The attached cells were cardiac fibroblasts, and the fibroblasts were cultured with complete medium.

[0050] 7.2 Primary cardiomyocyte culture

[0051] Fibroblasts and cardiomyocytes were separated by differential adhesion method. The adherent cells were cardiac fibroblasts and the cell suspension was cardiomyocytes. After centrifugation, the precipitate was resuspended in complete medium. The cardiomyocytes were counted using a cell counting plate and inoculated into 6-well plates for culture. Cell growth was observed under an inverted microscope. Co-culture of primary cardiac fibroblasts and cardiomyocytes

[0052] After culturing primary cardiomyocytes and cardiac fibroblasts separately, cardiomyocytes and fibroblasts were co-cultured using Transwell chambers, with fibroblasts seeded in the upper chamber and cardiomyocytes seeded in the lower chamber.

[0053] 8. Identification of primary cell purity

[0054] Neonatal rat cardiac fibroblasts and cardiomyocytes were transferred to glass-bottomed dishes. When the cell density reached about 60%, they were washed with 1 ml PBS for 3 times, each time for 1 min. 4% paraformaldehyde, 0.4 ml / well, fixed at room temperature for 2 hours, washed with 1 ml PBS for 3 times, each time for 1 min. 5% Triton X-100 (prepared in PBS), 0.4 ml / well, permeabilized at room temperature for 20 min, washed with 1 ml PBS for 3 times, each time for 1 min. 3% H 2 O 2 ,, 0.4ml / well (4 drops), incubate at room temperature for 20min (eliminate endogenous peroxidase), rinse 3 times with 1ml PBS, 1min each time; normal goat serum, 0.4ml / well (4 drops), block at room temperature for 30min, rinse 3 times with 1ml PBS, 1min each time; PBS is prepared with primary antibody Vimentin (1:50) (primary cardiac fibroblasts), PBS is prepared with primary antibody α-SMA (1:100) (primary cardiomyocytes), 0.4ml / well, incubate on a shaker at 4℃ for 24h, rinse 3 times with 1ml PBS, 1min each time; PBS is prepared with fluorescent goat anti-mouse secondary antibody (1:100), 0.4ml / well, incubate at room temperature for 1h in the dark, rinse 3 times with 1ml PBS, 1min each time; add DAPI nuclear stain, 0.4ml / well, incubate for 5min in the dark, rinse 3 times with PBS for microscopy.

[0055] 9. CCK-8 assay

[0056] Inoculate the cell suspension (100ul / well) in a 96-well plate, place it in an incubator for culture (at 37°C, 5% CO2) after heat shock modeling, and measure CCK-8 at each time point of the experiment. Add 10ul of CCK-8 solution to each well, and be careful not to generate bubbles. Incubate the culture plate in the incubator for 1.5h, and measure the absorbance at 450nm with an enzyme marker.

[0057] 10. Western Blot

[0058] Cell protein was extracted, and an appropriate amount of RIPA Lading Buffer was added. The protein content of each sample was calculated using a BCA quantitative kit. The total protein was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane. The cells were incubated with Caspase-3, Cleaved Caspase-3, Bcl-2, and Bax antibodies at 4°C overnight, then incubated with horseradish peroxidase-labeled secondary antibodies, and finally developed.

[0059] 2. Statistical Analysis

[0060] SPSS23.0 statistical software and Graphad prism6 software were used for statistical analysis and drawing. Data were expressed as mean ± standard deviation (±SD), and one-way ANOVA was used for comparison among multiple groups. p<0.05 indicated that the difference was statistically significant.

[0061] 3. Results

[0062] 1. Cardiac function of heat shock mice

[0063] Twelve hours after the heat shock modeling, the activity of mice decreased significantly and they became listless. Cardiac ultrasound examination showed that the heat shock mice had cardiac dysfunction ( Figure 1-5 ).

[0064] Table 1 Cardiac function indexes of mice

[0065]

[0066] * P<0.05vs.Normal group

[0067] The applicant performed immunohistochemical staining on myocardial tissue before and after modeling to detect the in situ expression of apoptosis-related pathway proteins. The results showed that compared with the control group, the expression of pro-apoptotic proteins Bax and Cleaved-caspase3 in the heat shock group was significantly increased, and the expression of anti-apoptotic Bcl-2 protein was significantly decreased (P<0.05), indicating that myocardial cells were apoptotic ( Figure 6 , Figure 7 ). The results of mouse serum IL-6 inflammatory factor detection showed that compared with the normal group, the IL-6 of heat-shocked mice increased (P<0.05). This suggests that heat-shocked mice release inflammatory factors ( Figure 8 ).

[0068] 2. Purity identification of cardiac fibroblasts and cardiomyocytes

[0069] The cultured cardiac fibroblasts were observed under a fluorescence microscope with the primary antibody Vimentin and the fluorescent goat anti-mouse secondary antibody, and green fluorescence was observed. The cell nuclei stained with DAPI showed blue fluorescence. The purity of fibroblasts was 95%. The cultured cardiomyocytes were observed under a fluorescence microscope with the primary antibody a-SMA and the fluorescent goat anti-mouse secondary antibody, and red fluorescence was observed. The cell nuclei stained with DAPI showed blue fluorescence. The purity of cardiomyocytes was 95% ( Fig. 9 ).

[0070] 3. Effects of heat shock at different times and under different conditions on fibroblast viability

[0071] The viability of cardiac fibroblasts under different heat shock conditions (39℃, 41℃, 43℃) and at different times after rewarming (0h, 3h, 6h, 12h, 24h) was changed. The CCK-8 results showed that the survival rate of fibroblasts was the lowest after heat shock at 43℃ for 2 hours and rewarming for 12 hours, and the difference was statistically significant (P<0.05) (Table 2, Fig.10 ).

[0072] Table 2 Effects of heat shock at 43℃ for different rewarming times on fibroblast viability

[0073]

[0074] * p<0.05vs.control group

[0075] Table 3 Effects of heat shock at different temperatures on fibroblast viability

[0076]

[0077] * P<0.05vs.control group

[0078] Heat shock under different conditions (39℃, 41℃, 43℃) for 2 hours, rewarming for 12 hours, CCK-8 results showed that the survival rate of fibroblasts was the lowest when heat shock was 43℃ ​​for 2 hours and rewarming for 12 hours, and the difference was statistically significant (P<0.05). In subsequent experiments, the applicant used 43℃ heat shock for 2 hours and rewarming for 12 hours to treat cells ( Fig.11 ).

[0079] 4. Effect of heat shock on the release of inflammatory factors in fibroblasts

[0080] After heat shock at 43°C for 2 hours and rewarming for 12 hours, the levels of IL-1β, IL-6, and TNF-a in the cell supernatant were detected by ELISA. Figure 9-13As shown in the figure, the levels of IL-1β, IL-6, and TNF-a in the cell supernatant of heat-shocked fibroblasts increased significantly after 12 hours of rewarming, and the difference was statistically significant compared with the control group (P<0.05), indicating that heat-shocked cardiac fibroblasts release a large number of inflammatory factors, including TNF-a, IL-1β, IL-6 ( Fig.12 ).

[0081] 5. Effect of heat shock on apoptosis of cardiac fibroblasts and cardiomyocytes co-cultured

[0082] After co-culture of fibroblasts and cardiomyocytes with 43℃ heat shock for 2 hours and then rewarmed for 12 hours, the expression of Bax and Cleaved-caspase3 proteins was significantly higher than that of the control group (P<0.05), and the expression of Bcl-2 protein was lower than that of the control group, with statistically significant differences (P<0.05), indicating that heat shock co-cultured cardiac fibroblasts and cardiomyocytes caused cardiomyocyte apoptosis ( Fig.13 ).

[0083] 6. Effect of Delphinium monosome FYC-3 on fibroblast viability

[0084] According to the medicinal effects of delphinium, a new monomer FYC-3 ( Fig.14 , Fig.15 ), CCK-8 was used to observe the effect of delphinium monomer FYC-3 on fibroblast viability. The applicant used different concentrations of FYC-3 (0.001ug / ml, 0.01ug / ml, 0.1ug / ml, 1ug / ml, 5ug / ml, 10ug / ml) to pretreat fibroblasts for 1 hour, and tested CCK-8 to detect cell viability 12 hours later. The results showed that there was a statistically significant difference between 5ug / ml and 10ug / ml and the blank control group (P<0.05), indicating that 5ug / ml and 10ug / ml had obvious cytotoxicity and decreased cell survival rate. Therefore, the applicant selected 0.01ug / ml, 0.1ug / ml, and 1ug / ml concentrations as the follow-up experiments ( Fig.16 ).

[0085] Table 4 Effect of delphinium monomer FYC-3 on fibroblast viability

[0086]

[0087] * p<0.05vs.control group

[0088] 7. Effect of Delphinium monosome FYC-3 on the secretion of inflammatory factors in heat-shocked fibroblasts

[0089] The applicant used different concentrations of FYC-3 (0.01ug / ml, 0.1ug / ml, 1ug / ml) to pretreat fibroblasts, heat shock at 43°C for 2 hours and then rewarm for 12 hours, and then ELISA was used to detect the levels of IL-1β, IL-6, and TNF-a in the cell supernatant. Figure 9-14 As shown in the figure, the levels of IL-1β, IL-6, and TNF-a in the supernatant of heat-shocked fibroblasts increased significantly after 12 hours of rewarming, and the difference was statistically significant compared with the control group (P<0.05); however, after pretreatment with FYC-3, the levels of IL-1β, IL-6, and TNF-a in the supernatant of the cells decreased, and the difference was statistically significant ( Fig.17 ). This suggests that FYC-3 can reduce the release of inflammatory factors from heat-shocked cardiac fibroblasts.

[0090] 8. Effect of Delphinium FYC-3 pretreatment on cardiomyocyte apoptosis in cultured cardiomyocytes

[0091] The applicant used Western Blot to detect the expression of myocardial cell apoptosis-related proteins in myocardial cells cultured alone after pretreatment with Delphinium FYC-3. The results showed that the levels of Bax and Cleaved-caspase3 proteins in heat-shocked myocardial cells increased, and the level of Bcl-2 protein decreased. The levels of Bax, Cleaved-caspase-3, Bcl-2, and Caspase3 proteins in heat-shocked myocardial cells pretreated with FYC-3 did not change, and the difference was not statistically significant (P>0.05)( Fig.18 ). This suggests that Delphinium FYC-3 has no anti-apoptotic effect on heat shock-induced cardiomyocytes.

[0092] 9. Effect of Delphinium FYC-3 pretreatment on cardiomyocyte apoptosis in co-cultured fibroblasts and cardiomyocytes

[0093] The applicant used Western Blot to detect the expression of myocardial cell apoptosis-related proteins in co-cultured fibroblasts and cardiomyocytes pretreated with Delphinium FYC-3. The results showed that after FYC-3 pretreatment of co-cultured fibroblasts and cardiomyocytes, the levels of pro-apoptotic Bax and Cleaved-caspase proteins decreased, and the difference in pro-apoptotic activity between co-cultured fibroblasts and cardiomyocytes was statistically significant (P<0.05); the level of anti-apoptotic protein Bcl-2 protein increased, and the difference was statistically significant (P<0.05) ( Fig.19 ). This suggests that Delphinium FYC-3 has an anti-apoptotic effect on heat-shocked co-cultured cardiac fibroblasts and cardiomyocytes.

[0094] Discussion

[0095] The mechanisms of myocardial injury caused by HS include: direct thermal injury, leading to myocardial cell degeneration and necrosis; endothelial cell damage causing increased vascular permeability, microvascular embolism causing myocardial cell ischemia and hypoxia, edema and necrosis causing cardiac metabolic dysfunction; heat shock to myocardial cell mitochondrial damage, resulting in changes in mitochondrial membrane permeability, activation of caspase-3 causing myocardial cell apoptosis; oxidative stress-mediated myocardial injury. In addition, the release of cellular inflammatory factors also plays an important role in heatstroke cardiac dysfunction. HS is considered to be a severe disease of systemic inflammatory response syndrome caused by high fever. The levels of proinflammatory cytokines IL-lβ, TNF-α, IL-6, interferon, IL-8, and monocyte chemoattractant protein in the serum of patients with heatstroke are increased and positively correlated with the severity of the disease. The increase in plasma IL-1 levels causes a selective decrease in stroke volume or ventricular depolarization, which may be an important mechanism for hypotension or circulatory failure in rats with heatstroke.

[0096] The heart is composed of non-cardiomyocytes and cardiomyocytes, of which non-cardiomyocytes account for the majority, and cardiac fibroblasts are the most important non-cardiomyocytes, which are of great significance in maintaining cardiac function and promoting extracellular matrix. The applicant's study detected heat-shocked primary cardiac fibroblasts by the CCK-8 method and observed the effect on cell viability. The results showed that the cell survival rate was lowest after 43°C heat shock for 2 hours and rewarming for 12 hours. Therefore, in subsequent experiments, the applicant selected this time point as the research time. Studies have shown that the increase of inflammatory factors such as IL-6, IL-1, and TNF-a is an upstream stress signal for apoptosis of cardiomyocytes. Therefore, the applicant used ELISA to detect the supernatant of heat-shocked cardiac fibroblasts and found that it released a large amount of inflammatory factors IL-6, TNF-a, and IL-1β. To further study the connection between fibroblasts and cardiomyocytes, the applicant used Transwell chambers to co-culture a microenvironment in which fibroblasts and cardiomyocytes coexist. After heat shock modeling, the cells were rewarmed for 12 hours and Western Blot was used to detect the expression levels of Cleaved-caspase 3, Bcl-2, and Bax proteins. The results showed that the expression levels of Bax and caspase3 were increased, while the expression level of Bcl-2 was decreased.

[0097] Cell apoptosis is mainly divided into the apoptosis signal transduction stage, the central regulation stage and the gene structure stage. The apoptosis-related pathways include the endoplasmic reticulum, death receptors and mitochondrial pathways. The endoplasmic reticulum contains apoptosis-related proteins, among which Caspase-12 and Bcl-2 families are currently the most studied. Caspase is a cysteine ​​protease that promotes cell apoptosis. Elevated Caspase-3 is seen in myocardial ischemia, cardiomyopathy and heart failure. Casepase family proteases have two activation pathways: intrinsic activation pathway and extrinsic activation pathway. The intrinsic pathway is mediated by mitochondria. In mitochondria-dependent apoptosis, cytochrome C is released from mitochondria into the cytoplasm, leading to the activation of the initiator Caspase-9, thereby activating the effector Caspase-3. Caspase-3 proteolytically cleaves a series of cellular targets, ultimately leading to cell death. The Bcl-2 family has about 15 members, which are divided into the anti-apoptotic Bcl-2 subfamily and the pro-apoptotic Bax subfamily. Bcl-2 and Bax are the most important members, maintaining the balance between cell death and survival. Studies have shown that the ratio of Bcl-2 (anti-apoptotic) and Bax (pro-apoptotic) in cells largely determines whether the cells begin apoptosis or re-enter the cell cycle. Overexpression of Bax can lead to mitochondrial depolarization and cytochrome C release, leading to downstream activation of Caspase to increase apoptosis, while overexpression of Bcl-2 causes cells to continue to proliferate by antagonizing the apoptotic signal transmitted by pro-apoptotic Bax. Excessive activation of inflammatory response can lead to cardiomyocyte apoptosis. Therefore, the applicant believes that heat strikes fibroblasts to release inflammatory factors, promote the increase of pro-apoptotic proteins in cardiomyocytes, and reduce anti-apoptotic proteins, thereby causing cardiomyocyte apoptosis.

[0098] The above description is only a preferred embodiment of the present invention and does not limit the present invention in any form. However, any simple modification, equivalent change and modification made to the above embodiment according to the technical essence of the present invention without departing from the technical solution of the present invention still falls within the scope of the technical solution of the present invention.

Claims

1. Application of delphinium monomer FYC-3 in the preparation of drugs for the prevention and treatment of severe heatstroke and heart dysfunction.

2. The use according to claim 1, characterized in that: The medicine comprises delphinium monomer FYC-3 and pharmaceutically acceptable excipients.

3. The use according to claim 1 or 2, characterized in that: The dosage form of the drug includes injection, oral solution, pill, powder, paste, tablet, granule, powder or capsule.